15^th World Heart Congress

Regenerative Medicine and Stem Cell Therapy

Regenerative medicine and stem cell therapy represent a transformative frontier in cardiovascular research, offering innovative approaches to repair damaged heart tissue and restore cardiac function. Cardiovascular diseases often result in irreversible loss of cardiomyocytes following myocardial infarction or chronic heart failure, limiting the heart's natural ability to regenerate. Recent advances in stem cell biology, tissue engineering, biomaterials, gene editing, and regenerative therapeutics are creating new opportunities for cardiac repair and functional recovery. Researchers continue to investigate the therapeutic potential of mesenchymal stem cells, induced pluripotent stem cells, extracellular vesicles, and engineered cardiac tissues to improve myocardial regeneration and vascular repair while reducing fibrosis and inflammation.

This session will explore the latest developments in regenerative cardiovascular medicine, including stem cell therapies, cardiac tissue engineering, gene therapy, biomaterial scaffolds, translational research, and clinical applications. Experts will discuss ongoing clinical trials, mechanisms of cardiac regeneration, regulatory challenges, personalized regenerative therapies, and emerging technologies designed to improve long-term cardiovascular outcomes. The session provides a collaborative platform for clinicians, scientists, biomedical engineers, and industry leaders to exchange knowledge and accelerate the development of next-generation regenerative therapies for cardiovascular disease.